PCM
SMIHW

Prelude Capital Management’s Summit Healthcare Acquisition Corp. Warrant SMIHW Stock Holding History

Prelude Capital Management’s Portfolio SMIHW Stock Details SMIHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-29,187
Closed -$4K – 1783
2022
Q3 		$4K Hold
29,187
– – ﹤0.01% 1386
2022
Q2 		$2K Hold
29,187
– – ﹤0.01% 1729
2022
Q1 		$6K Hold
29,187
– – ﹤0.01% 1659
2021
Q4 		$19K Buy
+29,187
New +$17.5K ﹤0.01% 1841

Other funds holding SMIHW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
BP
BFAM Partners Northpoint, Hong Kong, Hong Kong $44K AUM 8.69% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SLC
Snow Lake Capital Central, Hong Kong $204M AUM 12.29% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
DACS
Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Prelude Capital Management's SMIHW Position: Q4 2022 in Review

Prelude Capital Management sold out of Summit Healthcare Acquisition Corp. Warrant (SMIHW) in Q4 2022, closing a stake of 29,187 shares — an estimated $4K sold.

Prelude Capital Management first reported a position in SMIHW in Q4 2021 and held it in 4 quarters. The position peaked at $19K in Q4 2021. 24 funds tracked by Wall St. Rank hold SMIHW as of Q4 2022.

  • Prelude Capital Management reported no remaining Summit Healthcare Acquisition Corp. Warrant position as of Q4 2022 after selling out during the quarter.
  • Prelude Capital Management sold 29,187 Summit Healthcare Acquisition Corp. Warrant shares in Q4 2022, an estimated $4K.
  • Prelude Capital Management first reported a position in Summit Healthcare Acquisition Corp. Warrant in Q4 2021 and held it in 4 quarters.
  • Prelude Capital Management's Summit Healthcare Acquisition Corp. Warrant position peaked at $19K in Q4 2021.
  • 24 funds tracked by Wall St. Rank held Summit Healthcare Acquisition Corp. Warrant as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.